Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Nerve block versus IV pain control after laparoscopic gallbladder removal

Official title: Paravertebral Block or External Oblique Intercostal Block? A Comparative Analysis of Pain and Opioid Consumption After Laparoscopic Cholecystectomy: A Randomized Controlled Trial

Run by Cukurova University · NCT07241949 · Data updated 2026-11-12

This trial will test whether two ultrasound-guided nerve blocks (paravertebral and external oblique intercostal) cut pain and tramadol use compared with IV patient-controlled tramadol in adults having elective laparoscopic gallbladder removal.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment147 (estimated)
SponsorCukurova University
Academic / other
Locations1 site (Adana)
StatusRecruiting
StartedDecember 1, 2025
Main results expectedNovember 1, 2026
Study endsDecember 5, 2026
Registry record updatedJuly 2, 2026
Trial IDNCT07241949 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with ASA physical status I–III scheduled for elective laparoscopic cholecystectomy who can give informed consent and are not chronic opioid users are ideal candidates.

Probably not a fit

Patients with contraindications to regional blocks (coagulopathy, local infection, allergy), severe hepatic or renal impairment, chronic opioid dependence, BMI >35, pregnancy or breastfeeding, or those who require conversion to open surgery are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This single-center, prospective, randomized, parallel-group trial will allocate adult patients undergoing elective laparoscopic cholecystectomy to bilateral thoracic paravertebral block, bilateral external oblique intercostal block, or standard systemic analgesia with IV patient-controlled tramadol. All regional blocks are performed under ultrasound guidance after induction of general anesthesia using standardized volumes and concentrations of a long-acting local anesthetic. The primary endpoint is total tramadol consumption within 24 hours after surgery, and secondary outcomes include pain scores, additional analgesic requirements, incidence of nausea/vomiting, time to mobilization, and length of hospital stay. The design tests whether truncal regional techniques provide opioid-sparing analgesia and faster recovery compared with systemic opioid-based regimens.

Why it matters

Potential benefit: If successful, targeted nerve blocks could reduce opioid use and pain after surgery, allowing earlier mobilization and fewer opioid-related side effects.

How similar studies have gone: Paravertebral and other thoracoabdominal fascial plane blocks have demonstrated opioid-sparing and pain-reducing effects in abdominal and thoracic surgery, while the external oblique intercostal block is less extensively studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 65 years
* Scheduled for elective laparoscopic cholecystectomy under general anesthesia
* ASA physical status I-III
* Able to understand the study procedure and provide informed consent

Exclusion Criteria:

Patient refusal or inability to provide informed consent

Allergy or contraindication to local anesthetics, tramadol, or study medications

Coagulopathy or current anticoagulant therapy

Local infection at the planned block injection site

Severe hepatic or renal impairment

Chronic opioid use or opioid dependence

Neurological or psychiatric disorders affecting pain perception or communication

Pregnancy or breastfeeding

Body mass index (BMI) \> 35 kg/m²

Conversion to open cholecystectomy during surgery

Where it's running

  • Cukurova University Faculty of Medicine
    Adana, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.